Stem Cell Banking
Cord Blood & Tissue
Stem Cell Packages
REPRODUCTIVE HEALTH
Immunogenetics
Genome Sequencing
Oncology
Screening
Health and Wellness
Learning Resources
Training service
Reproductive Health
Non-Invasive Prenatal Testing/Screening (NIPT/NIPS)
Reproductive Health Tests
Schedule Your Consultation Today
Take the first step toward personalized, non-invasive reproductive health insights.
Early, Safe, and Accurate Genetic Insights for Your Baby
Noninvasive Prenatal Testing (NIPT)—also known as non invasive prenatal screening (NIPS)—is a highly accurate method that analyzes fetal DNA found in the mother’s blood. This advanced technology can detect chromosomal conditions as early as 10 weeks into pregnancy, offering clear insights without posing any risk to the baby.
Conditions Detected by NIPT/NIPS
01
Trisomy 21 (Down Syndrome)
02
Trisomy 18 (Edwards Syndrome)
03
Trisomy 13 (Patau Syndrome)
04
Sex Chromosome Abnormalities
Empowering Parents with Early and Accurate Insights
Early Detection
Screens for chromosomal conditions such as Down, Edwards, and Patau syndromes as early as 10 weeks into pregnancy through a safe and advanced nipt lab test.
Safe Procedure
A non-invasive maternal blood test that poses no risk to the mother or baby—ideal for those looking for a reliable nipp test.
High Accuracy
Offers over 99% accuracy in identifying chromosomal abnormalities—giving parents peace of mind with trusted results.
Less Invasive
Minimizes the need for procedures like amniocentesis or chorionic villus sampling (CVS), making it a preferred choice for non invasive prenatal screening.
How Does NIPT/NIPS Work?
A safe, accurate way to learn more about your baby’s health—early in pregnancy.
Blood Collection
A small blood sample is taken from the mother, typically between the 10th and 14th week of pregnancy.
DNA Analysis
Fetal DNA in the mother’s blood is analyzed to check for extra or missing chromosomes using our advanced nipt lab test process.
Results
A detailed report is shared with your healthcare provider, highlighting potential genetic conditions with clarity and precision.
Why Choose FSG for (NIPT/NIPS)
01
Advanced
Technology
Technology
We use next-generation PCR systems, CRISPR-enhanced tools, and AI-powered analysis for precise and reliable nipt lab test results.
02
In house
testing
testing
All samples are processed in our own certified lab, ensuring faster delivery and full quality control—without third-party handling.
03
Fast
Turnaround
Turnaround
With on-site equipment and automated workflows, we deliver results quickly—so you and your doctor can make informed decisions sooner.
04
Data
security
security
We follow strict privacy protocols and data encryption standards to safeguard your personal and genetic information.
FAQ’s
Frequently Asked Questions!
We’re here to help. Explore answers or reach out to our team directly.
Noninvasive prenatal testing, also called non invasive prenatal screening, is a simple blood test that analyzes fetal DNA in the mother’s blood. It helps detect conditions like Down syndrome, Edwards syndrome, and Patau syndrome early and safely without posing any risk to the baby.
The cost of a nipt lab test in Dubai typically ranges from AED 1,800 to AED 3,000. Prices vary depending on whether the test includes screening for additional genetic conditions. At FSG, our in-house nipp test ensures fast, accurate results with full quality control.
While the primary goal of noninvasive prenatal testing is to detect chromosomal abnormalities, certain packages also check for the baby’s blood type, including Rh factor. This can be useful for managing Rh incompatibility during pregnancy.
A nipp test can determine your baby’s sex early by analyzing the presence of X or Y chromosomes in the mother’s blood. If only X chromosomes are detected, it indicates a female baby—adding gender insight to the broader benefits of non invasive prenatal screening.
Non-Invasive Prenatal Testing/Screening
Pre-Implantation Genetic Testing/Screening (PGT/PGS)
Male/Female Fertility
Rapid Prenatal & Pregnancy Loss
Maternal Cell Contamination (MCC)
Product of Conception (POC)
My HLA (Human Leucocyte Antigen)
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Low Pass Sequencing (1-3x Coverage)
Comprehensive Oncology Screening
Breast Cancer Screening (BRCA)
Cervical Cancer Screening
Prostate Cancer Screening
Heredity Cancer Panel
Leukemia Panel
Lymphoma Panel
Carrier Screening
Newborn Screening
Infectious Diseases Screening
Rare Diseases Screening
Consumer Genomics
Gut Metagenomics
Metagenomics
Personalized Medicine